0000899243-20-034578.txt : 20201218
0000899243-20-034578.hdr.sgml : 20201218
20201218213001
ACCESSION NUMBER: 0000899243-20-034578
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201216
FILED AS OF DATE: 20201218
DATE AS OF CHANGE: 20201218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AGUIAR ERIC
CENTRAL INDEX KEY: 0001262325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36847
FILM NUMBER: 201402185
MAIL ADDRESS:
STREET 1: 888 7TH AVENUE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invitae Corp
CENTRAL INDEX KEY: 0001501134
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 271701898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 374-7782
MAIL ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: InVitae Corp
DATE OF NAME CHANGE: 20121105
FORMER COMPANY:
FORMER CONFORMED NAME: Locus Development Inc
DATE OF NAME CHANGE: 20100910
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-16
0
0001501134
Invitae Corp
NVTA
0001262325
AGUIAR ERIC
C/O INVITAE CORPORATION
1400 16TH STREET
SAN FRANCISCO
CA
94103
1
0
0
0
Common Stock
2020-12-16
4
M
0
10000
24.16
A
10000
D
Common Stock
2020-12-16
4
S
0
6400
50.738
D
3600
D
Common Stock
2020-12-16
4
S
0
3600
51.4667
D
0
D
Stock Option (right to buy)
24.16
2020-05-02
4
M
0
10000
0.00
D
2029-05-02
Common Stock
10000
0
D
The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on August 7, 2020.
Represents a weighted average sale price. Actual sale prices ranged from $50.30 to $51.29 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents a weighted average sale price. Actual sale prices ranged from $51.33 to $51.81 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
The option was fully vested on May 2, 2020.
/s/ Thomas Brida, Attorney-in-Fact
2020-12-18